Pathfinders in Biopharma

Even in a boom, many biotech executives may be unprepared for the risks involved in undertaking an IPO. Noël Brown and Tim Papp, Managing Directors focused on biotechnology in our Global Healthcare Investment Banking and Jason Levitz, Head of Healthcare Equity Capital Markets at RBC Capital Markets discuss the right steps to take, and the pitfalls to avoid, in today’s markets.

In our launch edition of Pathfinders, we look at the best practices to follow on the road to IPO and the new predictive factors for success in today’s buoyant biopharma markets.